Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".
Folco
G
G
Center for Cardiopulmonary Pharmacology, Univ. of Milan, Italy.
Bolla
M
M
Santinelli
E
E
Bianco
S
S
Sestini
P
P
Mezzetti
M
M
Sala
A
A
D000098:Acetophenones / Q000494:pharmacology; D000109:Acetylcholine / Q000494:pharmacology; D001980:Bronchi / Q000187:drug effects* / Q000276:immunology; D001987:Bronchiectasis / Q000601:surgery; D002283:Carcinoma, Bronchogenic / Q000601:surgery; D003998:Dicarboxylic Acids / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology*; D007073:Immunoglobulin E / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007537:Isometric Contraction / Q000187:drug effects*; D020024:Leukotriene Antagonists; D008175:Lung Neoplasms / Q000601:surgery; D008565:Membrane Proteins; D009130:Muscle, Smooth / Q000187:drug effects* / Q000276:immunology; D011738:Pyrilamine / Q000494:pharmacology; D018077:Receptors, Leukotriene; D013189:SRS-A / Q000037:antagonists & inhibitors; D013777:Tetrazoles / Q000494:pharmacology
D000098:Acetophenones; D003998:Dicarboxylic Acids; D020024:Leukotriene Antagonists; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; D013189:SRS-A; D013777:Tetrazoles; D007073:Immunoglobulin E; D005665:Furosemide; C044660:LY 171883; C412375:cysteinyl leukotriene receptor 2; D011738:Pyrilamine; C083169:leukotriene D4 receptor; D000109:Acetylcholine; C052393:pobilukast; D007213:Indomethacin